In last trading session, Brainstorm Cell Therapeutics, Inc (NASDAQ:BCLI) saw 0.52 million shares changing hands with its beta currently measuring 0.21. Company’s recent per share
In the last trading session, 1.04 million shares of the Brainstorm Cell Therapeutics, Inc (NASDAQ:BCLI) were traded, and its beta was 0.25. Most recently the
Brainstorm Cell Therapeutics, Inc (NASDAQ:BCLI)’s traded shares stood at 1.03 million during the last session, with the company’s beta value hitting 0.27. At the close
In the latest trading session,, 50.33 million Brainstorm Cell Therapeutics, Inc (NASDAQ:BCLI) shares changed hands as the company’s beta touched 0.29. With the company’s most
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne